Alexander M. Lesokhin, MD
Myeloma Specialist & Cellular Therapist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Associate Attending Physician
I am an oncologist who specializes in treating people with multiple myeloma. The increase in new treatments in the past several years makes this a very exciting time for me and other specialists who care for people with this disease. Our team offers patients the highest-quality care as well as the newest treatments through clinical trials. These research studies will improve care and increase the chance of a good outcome for all of our patients.
Read more
My research work involves developing innovative ways to use the immune system to treat cancer. We are conducting clinical studies of medicines that enhance the immune response as well as laboratory studies aimed at understanding how cancers such as multiple myeloma are able to evade the immune response. We hope to develop new ways to treat our patients through these studies and through laboratory research.
A myeloma specialist is a doctor with special training in diagnosing and treating myeloma.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
My Specialties
- Multiple Myeloma
- Immunotherapy
Education
- MD, Albert Einstein College of Medicine
Residencies
- NewYork-Presbyterian Hospital/Columbia University Medical Center
Fellowships
- Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
- Hematology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Lesokhin sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Lesokhin
- A Phase 1 Study of Elranatamab With Iberdomide in People With Multiple Myeloma
- A Phase 1b Study of Elranatamab Plus Carfilzomib and Dexamethasone or Elranatamab Plus PF-07901801 in People With Multiple Myeloma
- A Phase I/II Study of Cevostamab Immunotherapy in People with Multiple Myeloma
- Smoldering Myeloma Registration Trial (SMRT Study)
Read more
- Clinical Trials Co-Investigated by Dr. Lesokhin
- A Phase 1 Study of ABBV-453 in People with Recurrent or Persistent Multiple Myeloma
- A Study Comparing a Plant-Based Diet with Supplements and Placebo in People with Monoclonal Gammopathy of Undetermined Significance or Smoldering Multiple Myeloma
- Stopping Maintenance Therapy in People with Multiple Myeloma in MRD-Negative Remission
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Lesokhin’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Alexander M. Lesokhin discloses the following relationships and financial interests:
-
Arcellx, Inc.
Professional Services and Activities -
Janssen Biotech, Inc.
Professional Services and Activities -
Pfizer, Inc.
Professional Services and Activities -
Roche
Professional Services and Activities
-
Serametrix
Intellectual Property Rights -
SVB Leerink
Professional Services and Activities -
Trillium Therapeutics Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].